HomeCompareNNLEX vs JNJ

NNLEX vs JNJ: Dividend Comparison 2026

NNLEX yields 10.08% · JNJ yields 3.36%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 NNLEX wins by $18.9K in total portfolio value
10 years
NNLEX
NNLEX
● Live price
10.08%
Share price
$18.91
Annual div
$1.91
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$39.0K
Annual income
$1,900.14
Full NNLEX calculator →
JNJ
Johnson & Johnson
● Live price
3.36%
Share price
$147.50
Annual div
$4.96
5Y div CAGR
5.8%
Payout ratio
55%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.0K
Annual income
$827.78
Full JNJ calculator →

Portfolio growth — NNLEX vs JNJ

📍 NNLEX pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodNNLEXJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, NNLEX + JNJ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
NNLEX pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

NNLEX
Annual income on $10K today (after 15% tax)
$857.18/yr
After 10yr DRIP, annual income (after tax)
$1,615.12/yr
JNJ
Annual income on $10K today (after 15% tax)
$285.83/yr
After 10yr DRIP, annual income (after tax)
$703.61/yr
At 15% tax rate, NNLEX beats the other by $911.51/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of NNLEX + JNJ for your $10,000?

NNLEX: 50%JNJ: 50%
100% JNJ50/50100% NNLEX
Portfolio after 10yr
$29.5K
Annual income
$1,363.96/yr
Blended yield
4.62%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

NNLEX
No analyst data
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
+55.1% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

NNLEX buys
0
JNJ buys
0
No recent congressional trades found for NNLEX or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricNNLEXJNJ
Forward yield10.08%3.36%
Annual dividend / share$1.91$4.96
Payout ratio50%55%
1-year div growth0%4.2%
5-year div CAGR0%5.8%
Portfolio after 10y$39.0K$20.0K
Annual income after 10y$1,900.14$827.78
Total dividends collected$14.5K$5.6K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: NNLEX vs JNJ ($10,000, DRIP)

YearNNLEX PortfolioNNLEX Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$11,708$1,008.45$10,676$355.77+$1.0KNNLEX
2$13,632$1,103.49$11,407$389.39+$2.2KNNLEX
3$15,786$1,200.69$12,198$426.53+$3.6KNNLEX
4$18,191$1,299.52$13,056$467.62+$5.1KNNLEX
5$20,864$1,399.50$13,987$513.12+$6.9KNNLEX
6$23,824$1,500.13$14,998$563.56+$8.8KNNLEX
7$27,093$1,600.93$16,098$619.52+$11.0KNNLEX
8$30,691$1,701.47$17,295$681.69+$13.4KNNLEX
9$34,641$1,801.33$18,599$750.82+$16.0KNNLEX
10$38,966$1,900.14$20,022$827.78+$18.9KNNLEX

NNLEX vs JNJ: Complete Analysis 2026

NNLEXStock

The fund primarily invests in common stocks of domestic corporations with small- and medium-sized market capitalizations believed to have growth potential. The advisor believes a company's annual sales volume and market capitalization are the factors most illustrative of a company's size. The advisor generally considers companies with market capitalizations up to $3 billion as "small", between $3 billion and $25 billion as "medium," and greater than $25 billion as "large."

Full NNLEX Calculator →

JNJHealthcare

Johnson & Johnson is a Dividend King with 62+ years of consecutive dividend increases. A healthcare conglomerate spanning pharmaceuticals, MedTech, and consumer health. JNJ spun off its consumer segment as Kenvue in 2023, focusing on higher-margin pharma and medical devices.

Full JNJ Calculator →
📬

Get this NNLEX vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

NNLEX vs SCHDNNLEX vs JEPINNLEX vs ONNLEX vs KONNLEX vs MAINNNLEX vs ABBVNNLEX vs MRKNNLEX vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.